Skip to main navigation

Home
About Us
Science
For Patients
- Patient Resources
- Clinical Trial
Join Cullinan
News
Contact Us
Investors

Back

Home
About Us
Science
For Patients
- Patient Resources
- Clinical Trial
Join Cullinan
News
Contact Us
Investors

Home
About Us
Science
For Patients
- Patient Resources
- Clinical Trial
Join Cullinan
News
Contact Us
Investors

Back

Home
About Us
Science
For Patients
- Patient Resources
- Clinical Trial
Join Cullinan
News
Contact Us
Investors

Event Details

Zipalertinib REZILIENT3 Results

September 14, 2026 8:00 AM EDT

Click Here for Webcast

Supporting Materials

Presentation 1.2 MB

Follow Us

Privacy Notice
Terms of Use
Cookie Notice
Accessibility Policy
Consumer Health Data Notice
Manage Cookie Consent

Do not sell or share my personal information

Limit the use of my sensitive personal information

© Copyright 2026
Cullinan Therapeutics, Inc.
| All Rights Reserved

Unless otherwise specified, CULLINAN, CULLINAN THERAPEUTICS, the Wing Logo, SCIENCE THAT MOVES, OUTRACE, REZILIENT, CLN, CGEM, and any other trademarks or trade dress appearing on this website are owned by or licensed to Cullinan Therapeutics, Inc. in the United States and other jurisdictions. Unauthorized use is strictly prohibited.

YOU ARE NOW LEAVING CULLINAN THERAPEUTICS’ WEBSITE

Cullinan Therapeutics does not control or influence the content on the page to which you are navigating.

Continue Cancel